Endoplasmic Reticulum (ER) stress of alveolar epithelial cells (AECs) is recognized as a key event of cell dysfunction in pulmonary fibrosis (PF). However, the mechanisms leading to AECs ER stress and ensuing unfolded protein response (UPR) pathways in idiopathic PF (IPF) remain unclear. We hypothesized that alveolar hypoxic microenvironment would generate ER stress and AECs apoptosis through the hypoxia-inducible factor-1α (HIF-1α). Combining ex vivo, in vivo and in vitro experiments, we investigated the effects of hypoxia on the UPR pathways and ER stress-mediated apoptosis, and consecutively the mechanisms linking hypoxia, HIF-1α, UPR and apoptosis. HIF-1α and the pro-apoptotic ER stress marker C/EBP homologous protein (CHOP) were co-expressed in hyperplastic AECs from bleomycin-treated mice and IPF lungs, not in controls. Hypoxic exposure of rat lungs or primary rat AECs induced HIF-1α, CHOP and apoptosis markers expression. In primary AECs, hypoxia activated UPR pathways. Pharmacological ER stress inhibitors and pharmacological inhibition or silencing of HIF-1α both prevented hypoxia-induced upregulation of CHOP and apoptosis. Interestingly, overexpression of HIF-1α in normoxic AECs increased UPR pathways transcription factors activities, and CHOP expression. These results indicate that hypoxia and HIF-1α can trigger ER stress and CHOP-mediated apoptosis in AECs, suggesting their potential contribution to the development of IPF.
1 January 2018 in Oxidative Medicine and Cellular Longevity
Background. Severe obstructive sleep apnea (OSA) with chronic intermittent hypoxia (IH) is common in idiopathic pulmonary fibrosis (IPF). Here, we evaluated the impact of IH on bleomycin‐ (BLM‐) induced pulmonary fibrosis in mice. Methods. C57BL/6J mice received intratracheal BLM or saline and were exposed to IH (40 cycles/hour; FiO2 nadir: 6%; 8 hours/day) or intermittent air (IA). In the four experimental groups, we evaluated (i) survival; (ii) alveolar inflammation, pulmonary edema, lung oxidative stress, and antioxidant enzymes; (iii) lung cell apoptosis; and (iv) pulmonary fibrosis. Results. Survival at day 21 was lower in the BLM‐IH group (p < 0.05). Pulmonary fibrosis was more severe at day 21 in BLM‐IH mice, as assessed by lung collagen content (p = 0.02) and histology. At day 4, BLM‐IH mice developed a more severe neutrophilic alveolitis, (p < 0.001). Lung oxidative stress was observed, and superoxide dismutase and glutathione peroxidase expression was decreased in BLM‐IH mice (p < 0.05 versus BLM‐IA group). At day 8, pulmonary edema was observed and lung cell apoptosis was increased in the BLM‐IH group. Conclusion. These results show that exposure to chronic IH increases mortality, lung inflammation, and lung fibrosis in BLM‐treated mice. This study raises the question of the worsening impact of severe OSA in IPF patients.
Background: Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive and fatal interstitial lung disease of unknown origin. Alveolar epithelial cells (AECs) play an important role in the fibrotic process as they undergo sustained endoplasmic reticulum (ER) stress, and may acquire a mesenchymal phenotype through epithelial-to-mesenchymal transition (EMT), two phenomena that could be induced by localized alveolar hypoxia. Here we investigated the potential links between hypoxia, ER stress and EMT in AECs. Methods: ER stress and EMT markers were assessed by immunohistochemistry, western blot and qPCR analysis, both in vivo in rat lungs exposed to normoxia or hypoxia (equivalent to 8% O2) for 48 h, and in vitro in primary rat AECs exposed to normoxia or hypoxia (1.5% O2) for 2–6 days. Results: Hypoxia induced expression of mesenchymal markers, pro-EMT transcription factors, and the activation of ER stress markers both in vivo in rat lungs, and in vitro in AECs. In vitro, pharmacological inhibition of ER stress by 4-PBA limited hypoxia-induced EMT. Calcium chelation or hypoxia-inducible factor (HIF) inhibition also prevented EMT induction under hypoxic condition. Conclusions: Hypoxia and intracellular calcium are both involved in EMT induction of AECs, mainly through the activation of ER stress and HIF signaling pathways.
1 January 2017 in Revue des Maladies Respiratoires
Background: Senescence is a critical cellular process involved in COPD progression. The molecular mechanisms that trigger senescence in small airways fibroblasts (SAF) are not clearly identified. These cells secrete proinflammatory cytokines and resist to apoptosis. In vitro studies suggest endoplasmic reticulum (ER) stress is important in COPD pathogenesis but whether this is linked to senescence is unknown. Aim: Assess the role of ER stress and the related unfolded protein response (UPR) pathways in fibroblast senescence in COPD. Methods: SAF were isolated from peripheral lung tissue from COPD patients and age-matched non-smokers (NS). Expression of senescence markers p21, p16, p-γH2AX and UPR pathway actors p-IRE1, p-PERK, p-eIF2α, ATF4, ATF6α were evaluated by Western blotting or immunocytochemistry. To link ER stress to senescence, protein expression of senescence markers was evaluated in SAF treated with ISRIB, a specific inhibitor of p-eiF2α. Apoptosis was measured using a caspase 3 activity assay in SAF exposed to cigarette smoke extract (CSE) (5%) treated with or without ISRIB. Results: p21, p16 and p-γH2AX were increased in COPD SAF (n=6, 57%, 27% and 62%) as well as UPR markers p-IRE1, p-PERK and p-eIF2α (n=6, 53%, 65% and 63%). COPD SAF showed also an elevated nuclear localization of the UPR transcription factors ATF4 and ATF6α (n=4). ISRIB treatment decreased expression of p21, p16 and p-γH2AX in COPD SAF (n=6). CSE induced more active caspase 3 positive cells in NS (n=2, 43%) than in COPD (n=2, 14%), ISRIB treatment restored the apoptotic effect of CSE in COPD SAF (n=2, 35%). Conclusion: ER stress, especially the p-eIF2α pathway, may play a role in primary SAF senescence in COPD suggesting that this molecular pathway could be targeted for new therapeutic strategies